ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Scientist.com Launches Clinical Labs Navigator™ to Expand Clinical Sourcing Capabilities

New solution streamlines clinical procurement, reduces costs, and accelerates study timelines

Scientist.com, the leading R&D procurement orchestration platform for the life sciences, today announced the launch of Clinical Labs Navigator™, a groundbreaking new tool that redefines how clinical trial services are sourced, managed, and executed. Developed in response to growing demand for more modern, collaborative procurement tools, Clinical Labs Navigator enables life science organizations to seamlessly engage with CROs while eliminating the inefficiencies of legacy processes. The platform delivers a more connected and compliant workflow, supporting streamlined communication, full budget digitization, and greater transparency across the clinical research lifecycle.

“Clinical Labs Navigator was built to meet the increasing need for integrated, efficient, and compliant solutions in clinical trial execution,” said Matt McLoughlin, SVP of Compliance & Categories at Scientist.com. “We’ve created a tool that not only helps clients streamline the design of clinical trials, through enhanced internal and external collaboration, but increases transparency throughout the study design and contracting process.”

The solution enhances platform workflows across several high-impact areas for both the sponsor and CRO:

  • Budget Digitization: Improved budget tracking and rate card adherence
  • Budget Management: Built-in cost modeling tools to improve and refine accuracy of budget estimates
  • Increased compliance: Enhanced audit trails to increase efficiency and compliance
  • Enhanced analytics: Improved reporting capabilities across various metrics

With this release, Scientist.com expands its clinical-stage portfolio to offer solutions across the entire development pipeline including Health Economics and Outcomes Research (HEOR), Real-World Evidence/Data (RWE/RWD), Market Access, GMP manufacturing, and late-stage biomarker development. Clinical Labs Navigator is particularly suited for organizations seeking to consolidate sourcing efforts, reduce study delays, and increase visibility across their global clinical operations.

The launch is a key milestone in Scientist.com’s broader mission to digitally transform the way research is conducted. By leveraging AI-enabled tools and deeply embedded compliance frameworks, the platform empowers researchers and procurement professionals to make smarter, faster decisions—ultimately accelerating the development of life-changing therapies.

To learn more about Clinical Labs Navigator™ and explore our full suite of clinical sourcing solutions, visit https://info.scientist.com/clinical

About Scientist.com

Scientist.com is the leading AI-enabled digital research platform for the life science industry. The platform simplifies drug discovery and development by streamlining procurement, accelerating innovation, ensuring regulatory compliance, and connecting researchers with a global network of pre-qualified suppliers. Scientist.com powers private marketplaces for the world’s largest pharmaceutical companies, over 100 biotech firms, and the US National Institutes of Health (NIH). Learn more at Scientist.com.

“Clinical Labs Navigator was built to meet the increasing need for integrated, efficient, and compliant solutions in clinical trial execution.”

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.